Abstract
Experimental analysis of allergic airway inflammation (AAI) in animals and humans is associated with coordinate gene induction. Using DNA microarray analysis, we have identified a large panel of AAI signature genes. Unexpectedly, the allergen-challenged lung (a T helper 2 microenvironment) was found to be associated with the expression of T helper 1-associated CXCR3 ligands, monokine induced by IFN-gamma (Mig), and IFN-gamma-inducible protein of 10 kDa (IP-10). Here we report that Mig functions as a negative regulator of murine eosinophils. Whereas Mig was not able to induce chemotaxis of eosinophils, pretreatment with Mig induced a dose-dependent inhibition of chemoattractant-induced eosinophil transmigration in vitro. Moreover, i.v. administration of low doses of Mig ( approximately 10-30 microg/kg) induced strong and specific dose-dependent inhibition of chemokine-, IL-13-, and allergen-induced eosinophil recruitment and, conversely, neutralization of Mig before allergen challenge increased airway eosinophilia. Importantly, Mig also inhibited a CCR3-mediated functional response in eosinophils. These results indicate that the ultimate distribution and function of inflammatory cells within the allergic lung is dictated by a balance between positively and negatively regulatory chemokines. The identification of a naturally occurring eosinophil inhibitory chemokine pathway in vivo provides a strategic basis for future therapeutic consideration.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Allergens / immunology
-
Animals
-
Chemokine CCL11
-
Chemokine CXCL9
-
Chemokines, CC / antagonists & inhibitors
-
Chemokines, CC / pharmacology
-
Chemokines, CXC / genetics
-
Chemokines, CXC / pharmacology*
-
Chemotaxis, Leukocyte / drug effects*
-
Endocytosis / drug effects
-
Eosinophils / cytology*
-
Eosinophils / drug effects*
-
Female
-
Gene Expression Regulation
-
Intercellular Signaling Peptides and Proteins / genetics
-
Intercellular Signaling Peptides and Proteins / pharmacology*
-
Interleukin-13 / antagonists & inhibitors
-
Interleukin-13 / pharmacology
-
Ligands
-
Lung / cytology*
-
Lung / drug effects
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Mice, Transgenic
-
Ovalbumin / antagonists & inhibitors
-
Ovalbumin / immunology
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Receptors, CCR3
-
Receptors, CXCR3
-
Receptors, Chemokine / metabolism
-
STAT6 Transcription Factor
-
Trans-Activators / deficiency
-
Trans-Activators / genetics
-
Trans-Activators / metabolism
-
Transcriptional Activation
Substances
-
Allergens
-
CCL11 protein, human
-
CCR3 protein, human
-
CXCL9 protein, human
-
CXCR3 protein, human
-
Ccl11 protein, mouse
-
Ccr3 protein, mouse
-
Chemokine CCL11
-
Chemokine CXCL9
-
Chemokines, CC
-
Chemokines, CXC
-
Cxcr3 protein, mouse
-
Intercellular Signaling Peptides and Proteins
-
Interleukin-13
-
Ligands
-
RNA, Messenger
-
Receptors, CCR3
-
Receptors, CXCR3
-
Receptors, Chemokine
-
STAT6 Transcription Factor
-
Stat6 protein, mouse
-
Trans-Activators
-
Ovalbumin